Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2007 October; 8(4): 51–56.
Published online 2007 October 19. doi:  10.1208/pt0804088
PMCID: PMC2750674

Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate


The purpose of the present study was to develop and characterize an oral controlled release drug delivery system for concomitant administration of diclofenac sodium (DS) and chondroitin sulfate (CS). A hydrophilic matrix-based tablet using different concentrations of hydroxypropylmethylcellulose (HPMC) was developed using wet granulation technique to contain 100 mg of DS and 400 mg of CS. Formulations prepared were evaluated for the release of DS and CS over a period of 9 hours in pH 6.8 phosphate buffer using United States Pharmacopeia (USP) type II dissolution apparatus. Along with usual physical properties, the dynamics of water uptake and erosion degree of tablet were also investigated. The in vitro drug release study revealed that HPMC K100CR at a concentration of 40% of the dosage form weight was able to control the simultaneous release of both DS and CS for 9 hours. The release of DS matched with the marketed CR tablet of DS with similarity factor (f2) above 50. Water uptake and erosion study of tablets indicated that swelling followed by erosion could be the mechanism of drug release. The in vitro release data of CS and DS followed Korsmeyer-Peppas and zero-order kinetics, respectively. In conclusion, the in vitro release profile and the mathematical models indicate that release of CS and DS can be effectively controlled from a single tablet using HPMC matrix system.

Full Text

The Full Text of this article is available as a PDF (173K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Tomford WW. Chondroprotective agents in the treatment of articular cartilage degeneration. Oper Tech Sports Med. 2000;8:120–121. doi: 10.1053/otsm.2000.6578. [Cross Ref]
2. Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthrit Cartil. 1998;6:39–46. doi: 10.1016/S1063-4584(98)80011-3. [PubMed] [Cross Ref]
3. Pipitone VR. Chondroprotection with chondroitin sulfate. Drugs Exp Clin Res. 1991;17:3–7. [PubMed]
4. Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthrit Cartil. 1998;6:14–21. doi: 10.1016/S1063-4584(98)80006-X. [PubMed] [Cross Ref]
5. Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Adv Drug Del Rev. 1993;11:37–57. doi: 10.1016/0169-409X(93)90026-Z. [Cross Ref]
6. Siepmann J, Kranz H, Bodmeier R, Peppas NA. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm Res. 1999;16:1748–1756. doi: 10.1023/A:1018914301328. [PubMed] [Cross Ref]
7. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today. 2000;3:198–204. doi: 10.1016/S1461-5347(00)00269-8. [PubMed] [Cross Ref]
8. Kiil S, Dam JK. Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements. J Control Release. 2003;90:1–21. doi: 10.1016/S0168-3659(03)00122-6. [PubMed] [Cross Ref]
9. Ford J, Rubinstein M, Hogan J. Propranolol hydrochloride and aminophylline release from matrix tablet containing hydroxypropyl methylcellulose. Int J Pharm. 1985;24:339–350. doi: 10.1016/0378-5173(85)90032-8. [Cross Ref]
10. Narasimhan B, Peppas NA. Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier. J Pharm Sci. 1997;86:297–304. doi: 10.1021/js960372z. [PubMed] [Cross Ref]
11. Zhang L, Li N, Zhao F, Li K. Spectroscopic study on the interaction between methylene blue and chondroitin 4-sulphate and its analytical application. Ana Sci. 2004;20:445–450. doi: 10.2116/analsci.20.445. [PubMed] [Cross Ref]
12. Lopes CM, Lobo JMS, Costa P, Pinto JF. Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release. Drug Dev Ind Pharm. 2006;32:95–106. doi: 10.1080/03639040500388482. [PubMed] [Cross Ref]
13. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133. doi: 10.1016/S0928-0987(01)00095-1. [PubMed] [Cross Ref]
14. Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-fickian release from non-swellable devices in the form slabs, spheres, cylinder or discs. J Control Release. 1987;5:23–36. doi: 10.1016/0168-3659(87)90034-4. [Cross Ref]
15. Donbrow M, Samuelov Y. Zero order drug delivery from double-layer porous films: release rate profiles from ethyl cellulose and polyethylene glycol mixtures. J Pharm Pharmacol. 1980;32:463–470. [PubMed]
16. Higuchi T. Rate of release of medicament from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874–875. doi: 10.1002/jps.2600501018. [PubMed] [Cross Ref]
17. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–1149. doi: 10.1002/jps.2600521210. [PubMed] [Cross Ref]
18. Korsmeyer RW, Gumy R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35. doi: 10.1016/0378-5173(83)90064-9. [Cross Ref]
19. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111. [PubMed]
20. Bolton S, Bon C. Pharmaceutical Statistics: Practical and Clinical Applications. New York, NY: Marcel Dekker; 2004.
21. Papadimitriou E, Buckton G, Efentakis M. Probing the mechanisms of swelling of hydroxypropyl methylcellulose matrices. Int J Pharm. 1993;98:57–62. doi: 10.1016/0378-5173(93)90041-D. [Cross Ref]
22. Melia CD. Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit Rev Ther Drug Carrier Syst. 1991;8:395–421. [PubMed]
23. Rowe RC, Sheskey RJ, Weller PJ. Handbook of Pharmaceutical Excipients. London, UK: Pharmaceutical Press; 2003.

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists